CC
MDCO

Clearline Capital’s Medicines Co MDCO Stock Holding History

Clearline Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-99,891
Closed -$2.73M – 64
2017
Q4 		$2.73M Buy
+99,891
New +$3.08M 1.41% 19
2017
Q3 		– Sell
-49,342
Closed -$1.88M – 58
2017
Q2 		$1.88M Buy
+49,342
New +$2.2M 1.18% 23

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Clearline Capital's MDCO Position: Q1 2018 in Review

Clearline Capital sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 99,891 shares — an estimated $2.73M sold.

Clearline Capital first reported a position in MDCO in Q2 2017 and held it in 2 quarters. The position peaked at $2.73M in Q4 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

  • Clearline Capital reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
  • Clearline Capital sold 99,891 Medicines Co shares in Q1 2018, an estimated $2.73M.
  • Clearline Capital first reported a position in Medicines Co in Q2 2017 and held it in 2 quarters.
  • Clearline Capital's Medicines Co position peaked at $2.73M in Q4 2017.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Clearline Capital's 13F filing for Q1 2018, filed 15 May 2018.